A
Ardent Health, Inc. (ARDT)
NYQ – Real Time Price. Currency in USD
10.07
+0.12 (1.21%)
At close: May 12, 2026, 4:00 PM EDT
10.07
0.00 (0.00%)
After-hours: May 12, 2026, 5:05 PM EDT
Find any stock by ticker or company name

NYQ – Real Time Price. Currency in USD
10.07
+0.12 (1.21%)
At close: May 12, 2026, 4:00 PM EDT
10.07
0.00 (0.00%)
After-hours: May 12, 2026, 5:05 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 2.12 | 1.59 | 10 | |
| Quick ratio | 2.00 | 1.27 | 10 | |
| Debt to Equity | 1.71 | 0.27 | 4.0 | |
| Debt to Assets | 0.44 | 0.72 | 5.0 | |
| Interest coverage | 7.53 | 25.51 | 10 | |
| Weighted average score | 7.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 5.13B | 5.41B | 5.97B | 6.32B | 6.43B |
| Gross Profit | 665M | 668M | 902M | 973M | 1.02B |
| Operating Income | 200M | 216M | 406M | 326M | 339M |
| Net Income | 189M | 54M | 210M | 136M | 134M |
| EBITDA | 338M | 357M | 552M | 481M | 502M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 0.11 | -51.59 | 1.5 |
| Next quarter | 3.96 | 247.18 | 7.0 |
| Current year | 3.89 | 17.79 | 6.5 |
| Next year | 4.39 | 14.44 | 6.0 |
| Weighted average score | 5.3 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -0.19 | -11.35 | -12.49 | -163.32 | 1.0 |
| Y/Y | 6.99 | -3.69 | -3.44 | -85.15 | 2.0 |
| 3y average | 7.25 | 61.11 | N/A | 98.85 | 6.5 |
| 5y average | 8.82 | 82.73 | N/A | -272.34 | 4.5 |
| Weighted average score | 3.5 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Total debt $2.3B significantly exceeds cash reserves ($609.7M), raising financial stability concerns
Total current assets $2.0B exceed Total current liabilities $951.5M, highlighting excellent liquidity
Debt-to-equity ratio (1.3) is near the industry average, reflecting balanced leverage
Interest coverage ratio (8x) indicates the company easily manages its debt payments
Negative free cash flow -$88.3M limits the company's ability to reinvest or pay down debt